SPRY Therapeutics, a SaaS platform for physical therapy professionals, raises $15 million in funding

Pune-based SaaS startup Spry Therapeutics has raised $15 million in a funding round led by Flourish Ventures.

Existing investors, including Together Fund, Fidelity’s Eight Roads Ventures, and F Prime Capital, also participated in the round.

The latest round brings its all-time raise to $25 million.

What does Spry Therapeutics do?

Spry Therapeutics, founded in 2021 by former Ola chief technology officer Brijraj Bhuptani and Riyaz Rehman, provides software solutions for healthcare centres, particularly those in the physical therapy segment.

The startup offers an integrated clinic management platform designed to serve the needs of physical therapists, occupational therapists, and speech-language pathologists.

The software helps clinics manage insurance claims, handle billing and payments, and automate administrative tasks. It also includes features for enhancing patient engagement and streamlining complex billing processes.

Unlike earlier cloud-based solutions, Spry Therapeutics provides a more comprehensive and automated approach, allowing clinics to focus on patient care while addressing financial and administrative challenges.

Utilizing funds for US expansion

With the fresh capital infusion, Spry Therapeutics plans to focus on expanding its operations in the US market.

The startup intends to set up a sales and service team to support its growth in the American healthcare sector, which has already seen significant traction.

In just 18 months, Spry has partnered with over 105 clinics across 30 US states. The company sees this market as a key area for growth, given the increasing demand for technology solutions that streamline clinical and administrative operations.

Previous funding and investors

Prior to this funding round, Spry Therapeutics raised $7 million in June 2022, led by Eight Roads Ventures and F Prime Capital. The startup also secured $3 million in seed funding from Together Fund.

Flourish Ventures, the lead investor in the current round, is known for its investments in early-stage companies, with a focus on financial and healthcare solutions.

The firm's portfolio includes several startups in India and Southeast Asia, such as Apnaklub, CredFlow, and Qoala, showcasing their interest in the rapidly growing healthcare SaaS segment.